← Back to Search

Cross-Sectional Group for High Blood Pressure

N/A
Recruiting
Led By Nitin Vaswani, MD
Research Sponsored by 80 Beats Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one visit (1hour)
Awards & highlights

Summary

80 Beats Medical introduces the VicorderCS, the next generation of our Vicorder technology designed to manage hypertension and cardiovascular risks. This advanced diagnostic equipment offers non-invasive collection and computation of a plethora of cardiovascular markers. It is faster, easier to use, and more portable than its predecessor, with enhanced connectivity options for extended marker collection and analysis. These markers enable early diagnosis of cardiovascular disease, ensuring positive patient outcomes. With a strong foundation in numerous published clinical studies, the VicorderCS enhances data collection and analysis capabilities, empowering the research community in developing new drugs and therapeutics. This validation study is purposed to evaluate one of the physiological parameters that is measured by the VicorderCS system, which is Non-invasive Blood Pressure (NIBP) via the common oscillometric cuff-based method.

Eligible Conditions
  • High Blood Pressure
  • Cardiovascular Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one visit (1hour)
This trial's timeline: 3 weeks for screening, Varies for treatment, and one visit (1hour) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Blood Pressure Reading
Secondary study objectives
Waveform Data

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cross-Sectional GroupExperimental Treatment1 Intervention
Blood pressure reading of one group of participants

Find a Location

Who is running the clinical trial?

80 Beats MedicalLead Sponsor
Nitin Vaswani, MDPrincipal InvestigatorPI
1 Previous Clinical Trials
10,000 Total Patients Enrolled
~80 spots leftby Aug 2025